Thyroid hormones affect plasma ghrelin and obestatin levels

Hormone and Metabolic Research

Volumn 43, Issue 2, 2011, Pages 121-125

  Kosowicz, J ^a   Baumann Antczak, A ^a   Ruchaa, M ^a   Gryczynska M ^a   Gurgul, E ^a   Sowinski J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

ghrelin; obestatin; thyroid hormones

Indexed keywords

GHRELIN; LIOTHYRONINE; OBESTATIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; THYROID CANCER; THYROIDECTOMY; THYROTOXICOSIS;

ADULT; FEMALE; GHRELIN; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROID HORMONES; THYROTOXICOSIS;

EID: 79551584746     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1269853     Document Type: Article

References (28)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660
2. Kojima M, Kangawa K. Structure and function of ghrelin. Results Probl Cell Differ 2008 46 89-115
3. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010 57 359-372
4. Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, Warren VA, Howard AD, Van Der Ploeg LH, Heck JV. Structure-function studies on the new growth-hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 2000 43 4370-4376
5. Matsumoto M, Kitajima Y, Iwanami T, Hayashi Y, Tanaka S, Minamitake Y, Hosoda H, Kojima M, Matsuo H, Kangawa K. Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues. Biochem Bioph Res Commun 2001 284 655-659
6. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Bioph Res Commun 2000 276 905-908
7. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001 120 337-345
8. Cummings DE, Weigle DS, Scott Frayo R, Breen PA, Ma MK, Dellinger P, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. NEJM 2002 346 1623-1630
9. Sedlackova D, Dostalova I, Hainer V, Beranova L, Kvasnickova H, Hill M, Haluzik M, Nedvidkova J. Simultaneous decrease of plasma obestatin and ghrelin levels after a high-carbohydrate breakfast in healthy women. Physiol Res 2008 57 S29-S37
10. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by ghrelin gene, opposes ghrelin's effects on food intake. Science 2005 310 5750 996-999
11. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, Perez-Tilve D, V?zquez MJ, Wiedmer P, Casta?eda TR, DiMarchi R, Tsch?p M, Schurmann A, Joost HG, Williams LM, Langhans W, Di?guez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007 148 21-26
12. Yamamoto D, Ikeshita N, Daito R, Hernongtyas EH, Toda K, Takahashi K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Peptides 2007 138 141-144
13. Gourcerol G, Coskun T, Craft LS, Mayer JP, Heimann ML, Wang L, Million M, St-Pierre DH, Tache Y. Preprogherlin - derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity 2007 15 2643-2652
14. Gourcerol G, Tache Y. Obestatin - a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroent Motil 2007 19 161-165
15. Mondal M, Toshinai K, Ueno H, Koshinaka K, Nakazato M. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents. J Endocrinol 2008 198 339-346
16. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2006 145 669-673
17. Monteleone P, Serritella C, Martiadis V, Scognamiglio P, Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 2008 93 4418-4421
18. Ngagya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H, Koh H, Yutani C, Kangawa K. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationship between ghrelin and anabaoli/catabolic factors. Circulation 2001 104 2034-2038
19. Butler MG, Bittel DC. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Gen 2007 143 415-421
20. Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V. Relation of plasma obestatin levels to bmi, gender, age and insulin. Horm Metab Res 2008 40 806-812
21. Zou CC, Liang L, Wang CL, Fu JF, Zhao ZY. The change in ghrelin and obestatin levels in obese children after weight reduction. Acta Pediatr 2009 98 159-165
22. Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol 2007 66 593-597 (Pubitemid 46434942)
23. Garg A. The ongoing saga of obestatin: is it a hormone? J Clin Endocrinol Metab 2007 92 3396-3398
24. Dalkjaer Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JOL. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003 88 853-857
25. Braclik M, Marcisz C, Giebel S, Orze A. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid 2008 18 545-550
26. Rojdmark S, Calissendorf J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 2005 27 55-61
27. Gjedde S, Vestergaard ET, Gormsen LCh, Dalkjar Riis AL, Rungby J, Moller N, Weeke J, Jorgensen LOL. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-Thyroxine treatment. J Clin Endocrinol Metab 2008 93 2277-2280
28. Lass P, Sawek J, Derejko M, Rubello D. Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging. Minerva Endocrinol 2008 33 75-84